# A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy.

> **NCT03190018** · NA · COMPLETED · sponsor: **Triomed AB** · enrollment: 5 (actual)

## Conditions studied

- Peritoneal Dialysis

## Interventions

- **DEVICE:** lCarry Life System Peritoneal Dialysis (CLS PD)

## Key facts

- **NCT ID:** NCT03190018
- **Lead sponsor:** Triomed AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2018-03-13
- **Final completion:** 2018-03-31
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03190018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03190018, "A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03190018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*